Spin-D: Safety and Cardiovascular Efficacy on Spironolactone in Hemodialysis Patients

Investigator

Jonathan Himmelfarb, MD

What is the Spin-D Study?

The goal of this study is to test the safety and effectiveness of Spironolactone in patients with kidney failure who are on hemodialysis. People with kidney failure have an increased risk of heart failure due to the thickening of the heart wall and an increased risk of abnormal heart rhythms. Spironolactone has been approved for treating heart failure; it is unknown whether this benefit occurs in patients with kidney failure.